Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Journal of Medical Genetics|November 8, 2023
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE studyEric L Wallace, Ozlem Goker-Alpan, William R Wilcox, et al.
Orphanet Journal of Rare Diseases|December 16, 2023
Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA projectIrene Serrano-Gonzalo, Laura López de Frutos, Carlos Lahoz-Gil, et al.
The New England Journal of Medicine|August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone MigalastatDominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
American Journal of Hematology|July 26, 2014
Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?Valentin García-Gutiérrez, Jose Manuel Puerta, Begoña Maestro, et al.
Annals of Hematology|November 18, 2018
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patientsValentín García-Gutiérrez, Dragana Milojkovic, Juan Carlos Hernandez-Boluda, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Pageof 16